Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4000310 | Urologic Oncology: Seminars and Original Investigations | 2011 | 8 Pages |
Abstract
Local symptoms do not confer worse prognosis compared with patients with incidentally detected UTUC. However, systemic symptoms are associated with worse outcomes despite apparently effective RNU. Patients with systemic symptoms may harbor micrometastatic disease and could potentially benefit from a more rigorous metastatic evaluation or perioperative chemotherapy regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jay D. M.D., Shahrokh F. M.D., Pierre I. M.D., Yair M.D., Arthur I. M.D., Marco M.D., Francesco M.D., Christian M.D., Alon Z. M.D., Jeffery C. M.D., Casey K. M.D., Douglas S. M.D., Mesut M.D., Matthias M.D., Christopher G. M.D., Vitaly M.D.,